# Charles Spence
热门播客单集
已更新:
Prof. charles spence is an experimental psychologist at the University of Oxford. He is the head of the Crossmodal Research group which specializes in the research about the integration of information across different sensory modalities.
Juho Jalkanen, CEO at Faron Pharmaceuticals on From Surgeon to CEO, Rethinking Boards, and Fighting for the Right Science
In this episode, I talked with Dr. Juho Jalkanen, CEO of Faron Pharmaceuticals — a publicly listed Finnish biotech building novel immunotherapies for blood cancers. Juho's path is unlike most you'll hear in biotech: trained vascular surgeon, PhD in molecular biology, business school graduate, and...
Episode 80: Playfulness, Creativity & Variability in Pain Rehab - Why It Doesn't Have to Be Boring
Rehabilitation for persistent pain often defaults to structure — sets, reps, progressions. But what happens when the people in front of you have already tried all of that? In this episode, Bart van Buchem and Tim Beames make the case for playfulness, creativity, variability, and abundance as genu...
What Makes Beer Taste Better? | Professor Charles Spence Explains the Science of Flavor
Why does the same beer taste incredible in one place and completely different somewhere else?
Professor Charles Spence has spent decades answering that exact question. As one of the world's leading researchers in sensory psychology, his work has influenced chefs, breweries, restaurants and hospit...
Michael Zaiac, Medical Affairs Lead for Oncology at Daiichi Sankyo on 30 Years of Hiring Lessons, The ADC Wave, and Building Teams in a Fast-Moving Pipeline
In this episode, I talked with Michael Zaiac, Medical Affairs Lead for Oncology across Europe and Canada at Daiichi Sankyo — a trained surgical oncologist who walked away from the operating table, moved through clinical development, bone health at P&G, GSK, and Celgene, and eventually landed at t...
Eating With Your Hands, Terrible Food Names & the Truth About Indian Cuisine
Is it ever okay to eat with your hands at a restaurant? George and Karla Walsh set the rules, rebrand the world's worst food names, and Chef Vivek Surti of Tailor Nashville explains why "curry" doesn't actually mean anything.
George Duran and Karla Walsh open the fine-dining rulebook and start cr...
He Knew Nothing About Beer… Then He Changed Beer Culture in Britain
What if everything you thought you knew about beer was wrong?
Rupert Ponsonby started his beer journey knowing almost nothing about beer. Using his background in wine, he asked a simple question: why couldn't beer have the same level of connoisseurship, storytelling and premium experience as wine...
Eliot Forster, CEO at Levicept on 30 Years in Pharma, Running a Six-Person Biotech, and the Future of European Drug Development
In this episode, I talked with Eliot Forster, CEO of Levicept, a neurophysiologist-turned biotech veteran with 30+ years of experience across Big Pharma and a series of CEO roles. We get into clinical failures, the realities of running a six-person company through a Phase 2 trial, and what it rea...
How Charles Spence's book Gastrophysics translates sound, shape and weight into pricing power
Charles Spence's book Gastrophysics argues that taste is built by every sense, not just the tongue. MichaelAaron and Richard work through the evidence: classical music lifting restaurant spend 10%, heavy cutlery raising willingness to pay 16%, rounder chocolate read as 50% creamier, and what bran...
Pawel Szczepanski, CEO at JJP Biologics, on Leading Without a Science Degree, Building Culture from Day One, and Why Trust Still Wins in Biotech Fundraising
In this episode, I talked with Pawel Szczepanski, CEO of JJP Biologics, a Polish biotech developing next-generation biologics in the personalized medicine space, to hear about his path from investment banking and management consulting into biotech leadership, and what it actually takes to build a...
Ann-Charlotte Rosendahl, CEO of Sobrera Pharma on Big Pharma to Biotech CEO, Building in an Overlooked Space, and Why Good Science Isn't Enough
In this episode, I talked with Ann-Charlotte Rosendahl, CEO of Sobrera Pharma, a clinical-stage Swedish biotech developing a novel combination treatment for alcohol use disorder. Ann-Charlotte brings close to 20 years in the pharmaceutical industry, including nearly 16 years at AstraZeneca where ...
